Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
12/28/2000 | WO2000078295A1 Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain |
12/28/2000 | WO2000078119A2 Cardiomyocytes with enhanced proliferative potential |
12/28/2000 | WO2000063348A3 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof |
12/28/2000 | WO2000058460A3 Casb619 involved in colon cancers |
12/28/2000 | WO2000056905A3 Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture |
12/28/2000 | WO2000053724A3 Compositions and methods for the modification of gene transcription |
12/28/2000 | WO2000049162A3 Compositions and methods for non-targeted activation of endogenous genes |
12/28/2000 | WO2000048614A3 Method for producing anti-tumor th1 cells |
12/28/2000 | WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes |
12/28/2000 | WO2000043495A3 33 human secreted proteins |
12/28/2000 | WO2000037640A3 Compositions and methods for the treatment of tumor |
12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
12/28/2000 | WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
12/28/2000 | WO2000030667A3 Compositions and methods using lactadherin or variants thereof |
12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
12/28/2000 | DE19929469A1 Producing feeder matrix dishes for culturing embryonic stem cells, comprises culturing feeder cells on a gelatin matrix and removing the cells |
12/28/2000 | DE19928866A1 Method for producing continuously changing images comprises growing colored fungal or bacterial cultures on a solid nutrient medium |
12/28/2000 | CA2377648A1 Prion protein peptides and uses thereof |
12/28/2000 | CA2377270A1 Cardiomyocytes with enhanced proliferative potential |
12/28/2000 | CA2377263A1 Polynucleotides and polypeptides encoded thereby |
12/28/2000 | CA2375869A1 Regulation system of expression using nuclear ppar receptors |
12/28/2000 | CA2375831A1 Plant multi-gene expression constructs |
12/28/2000 | CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci |
12/28/2000 | CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1 |
12/28/2000 | CA2375527A1 Method for enhancing hematopoiesis |
12/28/2000 | CA2375508A1 Methods and products for manipulating uncoupling protein expression |
12/28/2000 | CA2375505A1 Cell culture systems and methods for organ assist devices |
12/28/2000 | CA2375493A1 Human transport proteins |
12/28/2000 | CA2375480A1 Head trauma induced cytoplasmatic calcium binding protein |
12/28/2000 | CA2375414A1 Human transcriptional regulator proteins |
12/28/2000 | CA2375407A1 Rna metabolism proteins |
12/28/2000 | CA2375207A1 Peptide having preptin functionality |
12/28/2000 | CA2373391A1 Spheroid preparation |
12/28/2000 | CA2370414A1 Rice sucrose synthase promoter |
12/28/2000 | CA2340329A1 Method of increasing the resistance of cultivated plants to phytopathogenic fungi and bacteria by methods of molecular genetics |
12/28/2000 | CA2340319A1 Method for producing plants with increased flavonoid and phenolic compound content |
12/28/2000 | CA2340279A1 Method for increasing the resistance of cultivated plants to chemical stress |
12/27/2000 | EP1063300A2 A method of producing a taxane-type diterpene and method of obtaining cultured cells which produce the taxane-type diterpene at a high rate |
12/27/2000 | EP1063299A2 A method of producing a taxane-type diterpene and method of obtaining cultured cells which produce the taxane-type diterpene at a high rate |
12/27/2000 | EP1063298A2 Transgenic Animal Model for Alzheimer Disease |
12/27/2000 | EP1063297A1 Farnesyl pyrophosphate synthase (FPS) derived from seedlings of sunflower (Helianthus annus) |
12/27/2000 | EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
12/27/2000 | EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
12/27/2000 | EP1063289A1 Liver cell clones for artifical liver and extracorporeal liver assist device |
12/27/2000 | EP1062614A1 Methods for making character strings, polynucleotides and polypeptides |
12/27/2000 | EP1062364A1 Qualitative differential screening |
12/27/2000 | EP1062363A1 Method for producing agents for treating tumour diseases and for immunosuppression |
12/27/2000 | EP1062356A2 Pathogen-inducible promoter |
12/27/2000 | EP1062349A2 Diisopropyl fluorophosphatase and the utilization and production thereof |
12/27/2000 | EP1062345A1 Biosynthetic genes for spinosyn insecticide production |
12/27/2000 | EP1062344A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
12/27/2000 | EP1062343A1 Adp-glucose transporter of the amyloplast |
12/27/2000 | EP1062339A2 Human fgf gene and gene expression products |
12/27/2000 | EP1062338A2 Human membrane spanning proteins |
12/27/2000 | EP1062334A1 Mammalian sodium channel proteins |
12/27/2000 | EP1062333A1 Chondrosarcoma associated genes |
12/27/2000 | EP1062332A2 Human receptor proteins; related reagents and methods |
12/27/2000 | EP1062331A1 Compounds related to pap-1 |
12/27/2000 | EP1062330A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
12/27/2000 | EP1062326A1 Glycosyl sulfotransferase-3 |
12/27/2000 | EP1062324A2 Medium and method for viral propagation and growth |
12/27/2000 | EP1062323A2 Methods of diagnosis and triage using cell activation measures |
12/27/2000 | EP1062322A2 A living chimeric skin replacement |
12/27/2000 | EP1062321A1 Uses for humane non-autologous mesenchymal stem cells |
12/27/2000 | EP1062320A1 Methods and compositions for the selective expansion of gamma/delta t-cells |
12/27/2000 | EP1062319A1 Vascular endothelial growth factor 2 |
12/27/2000 | EP1062317A2 Method for decomposing biological material |
12/27/2000 | EP1062246A1 Anti-inositolphosphoglycan monoclonal antibodies |
12/27/2000 | EP1062238A1 Ecr673: a 7-transmembrane g-protein coupled receptor |
12/27/2000 | EP1062236A1 31 human secreted proteins |
12/27/2000 | EP1062234A2 Mammalian blood loss-induced gene, kd312 |
12/27/2000 | EP1062233A1 Secreted proteins and polynucleotides encoding them |
12/27/2000 | EP1061949A1 Use of cytokines and mitogens to inhibit graft versus host disease |
12/27/2000 | EP1061940A2 Use of follistatin to modulate gdf-8 and bmp-11 |
12/27/2000 | EP1061937A1 Improved radiation therapy methods |
12/27/2000 | EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
12/27/2000 | EP1061798A1 Non-human transgenic mammal, method for producing same and its use |
12/27/2000 | EP1061794A1 Methods for plant transformation and regeneration |
12/27/2000 | EP0804483B1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
12/27/2000 | EP0671909B1 Syndecan stimulation of cellular differentiation |
12/27/2000 | CN1278302A Adenovirus vectors and method for reducing homologous recombination phnomena |
12/27/2000 | CN1278299A Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
12/27/2000 | CN1278185A Compact epstein-barr virus peplicons |
12/27/2000 | CN1278008A Method for establishing animal mammary gland bio-reactor |
12/27/2000 | CN1059836C Production of inactivated vaccine for epidemic hemorrhagic fever using primary cells of kidney of golden yellow hamster |
12/26/2000 | US6166306 Method of producing hybrid catharanthus using male sterility |
12/26/2000 | US6166294 Nucleotide sequences which are expressed at preferential time during plant development for more efficient production of plant by-product |
12/26/2000 | US6166293 Method of increasing growth and yield in plants |
12/26/2000 | US6166290 Glutathione-S-conjugate transport in plants |
12/26/2000 | US6166288 Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor |
12/26/2000 | US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy |
12/26/2000 | US6166192 PGC-1, a novel brown fat PPARγ coactivator |
12/26/2000 | US6166190 Isolated nucleic acid molecule encoding human skeletal muscle-specific ubiquitin-conjugating enzyme |
12/26/2000 | US6166185 Antibodies to human TIE-2 ligands |
12/26/2000 | US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections |
12/26/2000 | US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents |
12/26/2000 | US6165791 Nucleotide sequences which prevent the transcription of genes associated with an activator of transcription; for the treatment of cell proliferation defects; antiproliferative agents; anticarcinogenic agents |
12/26/2000 | US6165787 Regulated transcription of targeted genes and other biological events |
12/26/2000 | US6165785 Culturing tissues; mixing stem cells, spleen aggregates, interleukins, lipopolysaccharides, colony stimulating factors, tumor necrosis factor and antibodies, maintain for time period, recover immunomodulatory cells, insert in human |